Mast Therapeutics
company
About
Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.
- 11 - 50
Highlights
Details
- Last Funding Type
- Post-IPO Debt
- Last Funding Money Raised
- $15M
- Industries
- Biopharma,Biotechnology,Health Care
- Founded date
- Jan 1, 1995
- Number Of Employee
- 11 - 50
- Operating Status
- Close
(NYSE MKT: MSTX) We are a San Diego-based biopharmaceutical company developing proprietary product candidates to treat various diseases and conditions.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$15M
Mast Therapeutics has raised a total of
$15M
in funding over 2 rounds. Their latest funding was raised on
Mar 1, 2016 from a Post-IPO Debt round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 1, 2016 | Post-IPO Debt | $15M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Mast Therapeutics is funded by 1 investors.
Hercules Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Hercules Capital
|
— | Post-IPO Debt |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
